Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 408Recruiting 128Terminated 83Unknown 66Active not recruiting 51Withdrawn 26Not yet recruiting 17Enrolling by invitation 7Suspended 3Available 2No longer available 1Approved for marketing 1

Sponsor Class

INDUSTRY 2NIH 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 46Gastrointestinal 8Thoracic 3Gynecologic 3Genitourinary 3Head & Neck 2Sarcoma 1Plasma cell 1Dermatologic 1CNS 1

Conditions

Prostatic Neoplasms 26Carcinoma, Renal Cell 10Melanoma 4Urinary Bladder Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Colorectal Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Pancreatic Neoplasms 2Kidney Neoplasms 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Radiation Injuries 1Prostatic Hyperplasia 1Penile Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Nocturia 1Nephrolithiasis, Calcium Oxalate 1Multiple Myeloma 1Metastatic Castration Resistant Prostate Cancer (mCRPC) 1Metastatic Castrate Resistant Prostate Cancer 1Mesothelioma 1

Interventions

Specimen Handling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Suspended × Breast Neoplasms × Genitourinary × Clear all
NCT04955808 2026-05-13

Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

National Cancer Institute (NCI)

Suspended
2,400 enrolled
BreastGastrointestinalGenitourinaryPlasma cell

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Carcinoma, Hepatocellular, Multiple Myeloma, Prostatic Neoplasms

NCT04714983 2024-04-09

DNX-2440 for Resectable Colorectal Liver Metastasis

DNAtrix, Inc.

Phase 1 Suspended
30 enrolled
BreastDermatologicGastrointestinalGenitourinarySarcoma

Breast Neoplasms, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Melanoma, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Gastrointestinal Stromal Tumors

NCT00909558 2010-02-24

Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer

Envita Medical Center, Inc.

Phase 1 Suspended
24 enrolled
BreastCNSGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Glioma, Liver Neoplasms, Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡